DELTA HEALTH GROUP
*NewsFlash* DELTA HEALTH GROUP rolls out its premier, directly managed, multi-specialty, US FDA Phase 2 / Phase 3 clinical trial sites in Asia
SPEARHEADING MEDICAL INNOVATIONS
The DELTA HEALTH GROUP is an international healthcare conglomerate focused on providing a comprehensive portfolio of innovative clinical drug development expertise, a worldwide network of dedicated, premier clinical trial investigative sites, global telemedicine facilities and intercontinental medical care.
About Us
Our Journey
Initially starting with the operation of a group of successful clinical trial investigative sites in the United States at the time of embarking on its journey more than two decades back, the DELTA HEALTH GROUP has progressively evolved and diversified its capabilities in clinical drug development and international healthcare.
We have been assisting partners in the healthcare sector optimize and develop new chemical entities, reformulated drug products, biologics and medical devices that aim to offer advanced therapies and an improvement to available patient care.
Our A-Team
Backed by a time-tested, proven track record spanning over 20+ years, the highly talented and experienced "Best-in-Class Specialty Providers" of our "A-Team" have designed and led full clinical development programs that have resulted in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA) and Health Canada.
These drugs are being used to treat patients in the United States, Canada and a number of other countries around the world.
We Strive To Develop Improved Treatment Options For Patients
Our Expertise Differentiates Us From Others
We are one of the privileged few in the healthcare industry having extensive experience with in-person, face-to-face interactions and successful working collaboration with the United States FDA for clinical development programs related to drugs, biologics and medical devices.
Over two decades of active engagement in this exercise has provided us an edge over others, with more depth and better understanding of the FDA approval process for drug products going through clinical development.
Unrelenting Commitment To Excellence
With an unrelenting commitment to excellence, our expertise and agility in global clinical trial management has been championed with deep knowledge and hands-on experience acquired from successfully directing numerous Phase 1 studies and more than 800 US FDA Phase 2 / Phase 3 clinical trials for drugs, biologics and medical devices.
Our extensive experience with the US FDA gives us the ability to recognize what it takes for a clinical development program to be successful. One of the main areas of this visibility is in the management of studies conducted under the supervision of the DELTA HEALTH team at our selected clinical trial investigative sites.
With an acquired acumen for the US FDA clinical drug development process, the DELTA HEALTH team is a reliable partner to co-develop investigational medical products and advance them in the development cycle through final regulatory approval.
Our Global Reach
Cross-Functional Teams
-
The DELTA HEALTH GROUP global teams include dedicated clinical drug development professionals, clinical trial physician investigators, CT site specialists and drug safety / PV experts
-
The clinical development and clinical trial site teams have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world (CLIN DEV - CLINICAL TRIAL SITES)
-
The DELTA HEALTH telemedicine group includes U.S. Board Certified Medical Specialists, U.K. General Medical Council Specialists and other therapeutic area physicians (INTERNATIONAL TELEMEDICINE)
-
Our Advisory Board includes prestigious names in the world of medicine, including physicians on the faculty of major hospitals and university medical centers in the United States, Canada and the United Kingdom
-
To complement our international medical teams, the DELTA HEALTH GROUP is supported by experts from our INTERCONTINENTAL MEDICAL CARE DIVISION (INTERCONTINENTAL MEDICAL CARE)